FDA grants Fast Track designation to DPTX3186, Dewpoint’s first in class condensate modulator for gastric cancerDesignation provides increased ...
The Fraunhofer Institute for Photonic Microsystems IPMS in Germany is a leading research institute in the area of spatial light modulators (SLMs), a technology that is of great relevance to Japan’s ...
While exploring Paradise Island, you might notice glowing rifts indicating tears in space and time. If you jump into one, you ...
Vitamin D is vital for health, but too much can be harmful, leading to hypercalcemia. Dr. Eric Berg highlights the Coimbra ...
A Rhinelander family is navigating treatment, and learning what their sons future looks like, after his Cystic Fibrosis ...
Baystreet.ca News Commentary – The global biologics industry is experiencing unprecedented expansion as the market surges toward $679.56 billion by 2030[1] driven by precision ...
AI can help humans reach their cognitive “flow state,” says author Mithu Storoni, by balancing challenge and ability.
The U.S. Food and Drug Administration (FDA) has granted orphan drug designation to DPTX3186, an investigational therapy being developed by Dewpoint Therapeutics for gastric cancer, according to a news ...
- These 52-week data reinforce HTD1801's potential as a truly differentiated therapeutic to concurrently address metabolic dysregulation, inflammation, and renal progression in type 2 diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback